High incidence of CDA deficiency in patients with hematological malignancies: perspectives and therapeutic implications

Ann Oncol. 2021 May;32(5):684-686. doi: 10.1016/j.annonc.2021.01.072. Epub 2021 Jan 30.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Hematologic Neoplasms* / complications
  • Hematologic Neoplasms* / epidemiology
  • Hematologic Neoplasms* / therapy
  • Humans
  • Incidence
  • Leukemia, Lymphocytic, Chronic, B-Cell*